Oregon Public Employees Retirement Fund’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$610K Buy
19,781
+400
+2% +$9.89K 0.01% 1167
2026
Q1
$419K Sell
19,381
-100
-0.5% -$2.16K 0.01% 1224
2025
Q4
$464K Buy
19,481
+3,900
+25% +$79.6K 0.01% 1179
2025
Q3
$212K Buy
15,581
+100
+0.6% +$1.04K ﹤0.01% 1392
2025
Q2
$126K Buy
15,481
+100
+0.7% +$854 ﹤0.01% 1468
2025
Q1
$121K Buy
15,381
+2,700
+21% +$31.3K ﹤0.01% 1474
2024
Q4
$189K Hold
12,681
﹤0.01% 1426
2024
Q3
$194K Sell
12,681
-600
-5% -$9.46K ﹤0.01% 1417
2024
Q2
$202K Sell
13,281
-1,200
-8% -$19.4K ﹤0.01% 1384
2024
Q1
$273K Sell
14,481
-1,300
-8% -$22.5K 0.01% 1339
2023
Q4
$301K Sell
15,781
-127
-0.8% -$2.03K 0.01% 1364
2023
Q3
$286K Sell
15,908
-500
-3% -$10K ﹤0.01% 1478
2023
Q2
$333K Sell
16,408
-400
-2% -$7.62K ﹤0.01% 1448
2023
Q1
$307K Sell
16,808
-531
-3% -$10.1K ﹤0.01% 1474
2022
Q4
$359K Buy
17,339
+78
+0.5% +$2.15K ﹤0.01% 1425
2022
Q3
$452K Buy
17,261
+1,961
+13% +$51.9K 0.01% 1302
2022
Q2
$388K Buy
+15,300
New +$375K 0.01% 1230

Other funds holding RCUS

Oregon Public Employees Retirement Fund's RCUS Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Arcus Biosciences (RCUS) stake by 2.1% in Q2 2026, buying an estimated $9.89K and bringing the position to 19,781 shares worth $610K. The position accounts for 0.01% of the portfolio, ranked #1167.

Oregon Public Employees Retirement Fund first reported a position in RCUS in Q2 2022 and has held it in 17 quarters since. 72 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 19,781 shares of Arcus Biosciences worth $610K as of Q2 2026.
  • Oregon Public Employees Retirement Fund bought 400 Arcus Biosciences shares in Q2 2026, an estimated $9.89K.
  • Arcus Biosciences made up 0.01% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #1167 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Arcus Biosciences in Q2 2022 and has held it in 17 quarters since.
  • 72 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.